Pharmacology for Nurses · Anti-infective Drugs
Introduction to HIV, AIDS, and Antiretrovirals
On this page 9 sections
In 30 seconds
Human immunodeficiency virus (HIV) is a Retrovirus RNA virus that copies its RNA into DNA to infect cells Full entry → that infects cells of the immune system — most importantly CD4+ T lymphocytes (helper T cells), which coordinate the body's defenses. Unlike most viruses, HIV carries its genetic information as RNA. To reproduce, it converts that RNA into DNA using an enzyme called Reverse transcriptase Viral enzyme converting viral RNA into DNA Full entry →, inserts the viral DNA into the host cell's genome with Integrase Viral enzyme splicing viral DNA into the host genome Full entry →, and finally assembles new virus particles with the help of Protease Viral enzyme trimming proteins so new viruses mature Full entry →, which trims viral proteins into their functional form.
Untreated, HIV progresses through recognizable stages. The acute (primary) infection occurs within weeks of exposure, often with flu-like symptoms and a very high Viral load Amount of HIV RNA in the blood Full entry →. A long chronic (clinical latency) phase follows, during which the person may feel well for years while CD4+ cells are slowly destroyed. When the CD4+ count falls very low — classically below 200 cells/mm³ — the person meets the clinical definition of acquired immunodeficiency syndrome (AIDS) and becomes vulnerable to opportunistic infections (such as Pneumocystis pneumonia or tuberculosis) and certain cancers (such as Kaposi sarcoma).
Antiretroviral therapy (ART Antiretroviral therapy — combination treatment suppressing HIV Full entry →) does not cure HIV, but it can suppress viral replication so effectively that the immune system recovers and life expectancy approaches normal. The key idea: combination therapy attacks several steps of the viral life cycle at once, making it very hard for the virus to escape.
Why this matters
HIV care is a global health priority and a core part of anti-infective pharmacology. For nurses: screening and early recognition catch infections in people who feel fine; prevention education covers safer practices and preventive drug strategies (PrEP, PEP); adherence support keeps ART working, because missed doses let the virus rebound and develop resistance; and stigma reduction — person-first language ("a person living with HIV," not "an HIV patient") and nonjudgmental communication — determines whether people test, disclose, and stay in care. On exams, the life-cycle step targeted by each drug class is a frequently tested relationship.
The college version
Core Concepts
The HIV life cycle and where drugs intervene
In order: (1) entry — the virus binds and fuses with the CD4+ cell; (2) reverse transcription — viral RNA is copied into DNA; (3) integration — viral DNA is spliced into the host genome; (4) transcription/translation — the cell makes viral proteins; (5) assembly and maturation — protease trims proteins so new viruses become infectious. Each major antiretroviral class blocks one of these steps.
Classes of antiretroviral drugs (mechanisms only)
- NRTIs (nucleoside/nucleotide reverse transcriptase inhibitors) are faulty building blocks incorporated into the growing viral DNA chain, stopping it from extending (chain termination) — they block step 2.
- NNRTIs (non-nucleoside reverse transcriptase inhibitors) also block reverse transcriptase, but by binding a different site and distorting the enzyme.
- Protease inhibitors (PIs) block protease, so new particles are released immature and noninfectious — step 5.
- Integrase strand transfer inhibitors (INSTIs) block integrase, preventing viral DNA from entering the host genome — step 3.
- Entry inhibitors interfere with binding or fusion — step 1.
Specific drugs, doses, and schedules are selected by the prescriber based on resistance testing, interactions, and other health conditions — always verify against current references, the formulary, and prescriber orders.
Combination therapy and the resistance problem
HIV replicates rapidly and makes copying errors, so a single drug quickly faces resistant mutants. Combination ART — typically three active drugs from at least two classes — makes simultaneous resistance statistically unlikely. Viral load is the key monitor: effective therapy drives it to undetectable levels, which is the basis of U=U (undetectable = untransmittable): a person with durably suppressed virus does not transmit HIV sexually. Resistance still develops through missed doses, drug interactions that lower drug levels, or starting with an already-resistant strain.
Prevention: PrEP and PEP
PrEP (pre-exposure prophylaxis) is an antiretroviral regimen taken by HIV-negative people at ongoing risk. PEP (post-exposure prophylaxis) is a short, time-sensitive course started soon after a possible exposure — including occupational needlesticks — to stop infection from establishing. Both follow current guidelines and institutional protocols.
Nursing considerations
Nursing care centers on adherence, monitoring, and support. Teach that ART is lifelong and that stopping or skipping doses risks resistance. Monitor for treatment-related effects (which vary by class) and report concerns to the prescriber. Assess for opportunistic infections as CD4+ counts fall, screen for co-infections (tuberculosis, hepatitis), and support mental health, since depression and stigma are major reasons people leave care. Scope of practice varies by setting and jurisdiction.
Common Confusions
| Do Not Confuse | With | Difference |
|---|---|---|
| HIV | AIDS | HIV is the virus; AIDS is the advanced disease stage — a person can live with HIV for years without AIDS |
| NRTIs | NNRTIs | Both block reverse transcriptase, but NRTIs are faulty building blocks; NNRTIs bind a separate site and distort the enzyme |
| Reverse transcriptase | Protease | RT copies RNA into DNA early in the cycle; protease matures new viruses at the end |
| "Cure" | Suppression | ART suppresses, never eliminates; stopping therapy allows rebound |
| Undetectable viral load | No HIV | Suppressed, not absent — virus remains in reservoirs and therapy must continue |
| PrEP | PEP | PrEP is taken before exposure; PEP is started after exposure and is time-sensitive |
Eli explains
The same idea, in plain words
Explain it like I’m 10
HIV is a tiny invader that sneaks into your body's "army generals" (helper cells) and turns them into copy machines for more invaders. The medicines don't kill the invader directly — they block its copying steps, like removing the ink from a copier. Using three different blockers at once means that even if the invader learns to get past one, the others still stop it, so the army can stay strong.
Worked example
A person newly diagnosed with HIV is prescribed a three-drug ART regimen. At the first teaching session, the nurse explains the plan in plain language: one medicine stops the virus's copying machine, a second stops it from hiding its instructions in the cell, and a third stops new particles from maturing — "together they box the virus in." The nurse helps plan when doses fit the person's daily routine, warns that a missed dose gives the virus a chance to multiply and mutate, and explains the monitoring schedule: viral load and CD4+ count at intervals per current guidelines. When the person asks whether they can transmit HIV to a partner, the nurse explains U=U — with a durably undetectable viral load, sexual transmission does not occur — and reviews the partner's options (testing, PrEP). When the person mentions stigma at work, the nurse validates the concern, uses person-first language, and connects them with support services. That is the real shape of HIV nursing: pharmacology, adherence science, prevention counseling, and human dignity woven together.
Key takeaways
- HIV is a retrovirus: RNA genome; reverse transcriptase converts RNA → DNA; integrase inserts it into host DNA; protease matures new virions.
- Target cell: CD4+ T lymphocyte; progressive loss = immune deficiency. AIDS is the advanced stage (classically CD4+ < 200 cells/mm³ or an AIDS-defining infection — criteria follow current definitions).
- Each ART class blocks one step: NRTIs/NNRTIs → reverse transcription; INSTIs → integration; PIs → maturation; entry inhibitors → entry.
- Combination therapy is standard: three active drugs from at least two classes; goal = undetectable viral load.
- U=U: undetectable viral load = no sexual transmission — a powerful counseling point.
- Adherence prevents resistance: missed doses let the virus replicate and mutate.
- PrEP prevents infection before exposure; PEP is a time-sensitive course after exposure.
- Person-first, stigma-free communication improves testing, disclosure, and retention in care.
Check yourself
6 review questions from the chapter. Try each one, then open the answer.
Why is HIV called a retrovirus, and which enzyme converts its RNA into DNA?
Show answer
Because its genome is RNA that is copied into DNA — "backward" compared with most organisms. Reverse transcriptase performs that conversion.
List the major antiretroviral classes and the life-cycle step each blocks.
Show answer
NRTIs and NNRTIs block reverse transcription; INSTIs block integration; protease inhibitors block maturation; entry inhibitors block entry/fusion. (Specific regimens follow current guidelines and resistance testing.)
Why is combination therapy used instead of a single antiretroviral?
Show answer
HIV mutates rapidly, so a single drug is quickly defeated. Three active drugs from at least two classes make simultaneous resistance extremely unlikely.
What do CD4+ count and viral load tell us about a person living with HIV?
Show answer
CD4+ count reflects immune health; viral load reflects replication activity. Falling CD4+ and rising viral load indicate progression; the reverse indicates treatment success.
What does U=U mean, and why is it an important counseling point?
Show answer
Undetectable = untransmittable: a person with durably suppressed virus does not transmit HIV sexually. It reduces stigma and supports adherence.
How do PrEP and PEP differ, and why is timing critical for PEP?
Show answer
PrEP is an ongoing regimen before exposure; PEP is a short course started as soon as possible after exposure — delay sharply reduces effectiveness.
Study tools & related lessonsKey vocabulary · Related
Key vocabulary
- Retrovirus
- RNA virus that copies its RNA into DNA to infect cells
- CD4+ T lymphocyte
- Helper T cell that coordinates immunity; HIV's main target
- Reverse transcriptase
- Viral enzyme converting viral RNA into DNA
- Integrase
- Viral enzyme splicing viral DNA into the host genome
- Protease
- Viral enzyme trimming proteins so new viruses mature
- Viral load
- Amount of HIV RNA in the blood
- Opportunistic infection
- Infection exploiting a weakened immune system
- ART
- Antiretroviral therapy — combination treatment suppressing HIV
- PrEP / PEP
- Pre-exposure and post-exposure prophylaxis
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.